2025 Expert Speaker Faculty Dr Matt Wilson Founder & Chief Executive Officer uMed Ann Beliën, PhD Founder & CEO Rejuvenate Biomed Alessandra Vignola President - Cardiovascular & Metabolic Business Unit Worldwide Clinical Trials Natalia Castro Executive Director Worldwide Clinical Trials David Anderson PhD, Director, Science & Innovation Clinical Ink Brad Swanson Strategic Collaborations Manager Promega Karly Mather Senior Scientist AstraZeneca Martin Schain Director - PET imaging Antaros Medical Caitlin Langford, Ph.D. Senior Director of Product, Pharma Solutions Perspectum Mike Fantigrassi Head of Product National Academy of Sports Medicine Damian Bialonczyk Global Medical Lead - Metabolism Roche Adam Bell Vice President - Translational Development & Regulatory Affairs Neuraly Taysir Bader Biopharma Specialist Waters Corporation Justin Goodarz Chief Commercial Officer Verified Clinical Trials Andrew Young Chief Scientific & Medical Officer I2O Therapeutics Jay Caplan Co-founder & President Fractyl Health Belle van Rosmalen Director, Medical Development Eli Lilly & Co. Jacek Mokrosinski Senior Scientist Novo Nordisk Hong Chen Director - Search & Evaluation Novo Nordisk Jerry Colca Chief Scientific Officer Cirius Therapeutics Adam Bell Vice President - Translational Medicine & Regulatory Affairs Neuraly Marco Falasca Professor Universita Degli Studi Di Parma Scott Harris Chief Medical Officer Altimmune Zohar Barbash Chief Technology Officer Lembas Bio Elisa Araldi Professor University of Parma David Bearss President & Chief Executive Officer ,Co-Founder Biolexis Therapeutics David Glass Adjunct Professor Regeneron Jason Mastaitis Sr. Principal Scientist Regeneron Johan Fredrik Paulsson Director Novo Nordisk Robert Beardsley President & Chief Executive Officer Cirius Therapeutics Simon Bruce Vice-President - Drug Development Solutions ICON Ansarullah Associate Director - Metabolic Phenotyping Core, Centre for Biometric Analysis The Jackson Laboratory Jennifer Linge Chief Scientific Officer AMRA Medical Mitchell Steiner Chairman, President & Chief Executive Officer Veru Inc. Iris Grossman Chief Therapeutics Officer Eleven Therapeutics Register Full Event Guide Pre-Conference Day